Every new development has to go through a series of processes and in some fields, such as robotic rehabilitation, there are steps such as clinical validation that are essential. This is where the safety of the developments is evaluated and invaluable feedback is obtained from future end users.
These days we are carrying out experiments with our project partners, the Hospital Nacional de Parapléjicos de Toledo (with the remote support of Caixa Mágica Software and the Neural Rehabilitation Group), in order to obtain all this information as a fundamental part of the RehAnkle project. With this information from the end users together with the data set to be collected by the medical team we hope to achieve the project’s goal of achieving a level of development equivalent to a TRL-7.
This project is funded by the DIH-HERO initiative which in turn receives funding from the European Commission’s H2020 program under agreement number 825003. The partners in the project are Twente University, Eurecat, Istituto Italiano di Tecnología, Imperial College London, Scuola Superiore Sant’Anna, Tecnalia, German Aerospace Center (DLR), IMEC, ITechinic, Danish Technological Institue, Fraunhofer IPA, RWTH University Hospital Aachen, Politécnico di Milano, ETF Belgrade, ETHZurich, Fundacja Rozwoju Kardiochirurgii and CEA.
At Technaid we want to highlight that we value very positively that part of the economic efforts of all Europeans are being devoted to develop an industry that will improve the lives of all human beings.
